vcfirmsdirectory.com

Venture capital

Ascenta Capital

Ascenta Capital is a biotech-focused venture investor that makes concentrated investments in clinical-stage drug developers and supports management teams with strategic and operational experience.

Registered · United States
New investments · 12 months
Fund vehiclesPublic
6
6 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 25 Oct 2026, 02:04 CETSources: ascentacap.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round Ascenta Capital joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is Ascenta Capital right for your round?

Is Ascenta Capital a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
6
6 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

ASCENTA CAPITAL FUND I, L.P.US private fund · Active · United States · $325.1M gross assets · filed 28 Aug 2026
ASCENTA CAPITAL PROJECT IKIGAI SPV, L.P.US private fund · Active · United States · $5.6M gross assets · filed 28 Aug 2026
ASCENTA CAPITAL PROJECT HENRI SPV, L.P.US private fund · Active · United States · $2M gross assets · filed 28 Aug 2026
ASCENTA CAPITAL PROJECT TURING SPV, L.P.US private fund · Active · United States · $820K gross assets · filed 28 Aug 2026
ASCENTA CAPITAL PROJECT TERNARY SPV, LPUS private fund · Active · United States · $700K gross assets · filed 28 Aug 2026
ASCENTA CAPITAL PROJECT ARGOS SPV, L.P.US private fund · Active · United States · $367K gross assets · filed 28 Aug 2026
Deployed (new cheques)
Next fund expected

Latest investments

BetaRounds Ascenta Capital joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

1 round in the last 12 months

Round sizes, Ascenta Capital’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

ADARx PharmaceuticalsAlpha-9 OncologyAngitiaCardurion PharmaceuticalsIambic TherapeuticsLatigoOdyssey TherapeuticsOrsoBioTRIANA BiomedicinesTriveni Bioand 1 more

Portfolio and exits

Every company Ascenta Capital backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where Ascenta Capital puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet Ascenta Capital

Events where Ascenta Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet Ascenta Capital’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

28 Aug 2026Fund filingForm ADV filed by ASCENTA CAPITAL: 6 private funds, $334.6M in gross assets.SEC Form ADV · public record
17 Jun 2026New deal
30 Oct 2025New deal
16 Jul 2024New deal

Founders also look at

Frequently asked questions

Ascenta Capital is based in the United States.

6 fund vehicles are on public registers (SEC adviser filings), including ASCENTA CAPITAL FUND I, L.P., ASCENTA CAPITAL PROJECT IKIGAI SPV, L.P. and ASCENTA CAPITAL PROJECT HENRI SPV, L.P.

Sectors: Biotech, Life sciences. From the firm’s own website.

Backs science-driven biotech companies as they move from preclinical work into early human trials, partnering on candidates in Phase 1 and 2 and on multi-medicine platforms. Makes concentrated bets, keeps patient needs central, and offers strategic guidance, connections and resources beyond capital. From the firm’s own website.

Ascenta Capital lists 11 portfolio companies on its website, including ADARx Pharmaceuticals, Alpha-9 Oncology, Angitia, Cardurion Pharmaceuticals and Iambic Therapeutics.

Firms whose websites list some of the same companies include Atlas Venture, Delos Capital and Catalio Capital Management.

Know before Ascenta Capital’s next round is announced.

PRO tracks Ascenta Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

Ascenta CapitalGet Ascenta Capital’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.